Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

NCT00037622 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

100

Enrollment

INDUSTRY

Sponsor class

Stopped Safety concerns from other studies.

Conditions

Chronic Hepatitis B

Interventions

DRUG: ACH-126, 443 (beta-L-Fd4C)

Sponsor

Alexion Pharmaceuticals, Inc.